Aarti Industries Ltd

- Ongoing Zone 4 expansion project with new capacities coming online over next few quarters. - New multipurpose plant (MPP) at Zone 4 to be commissioned in Q4 FY26, enhancing product development flexibility. - Calcium Chloride facility commissioning expected in the current quarter at Zone 4. - New 4,000 TPA PEDA project at Zone 4 (Jhagadia) utilizing Ethylation raw materials, targeting agrochemical industry demand. - Strategic partnership with DCM Shriram for long-term chlorine supply to Zone 4 downstream chemicals facility. - Debottlenecking initiatives on MMA capacity to scale up volumes further from Q4 FY26. - Capex for FY26 expected around INR 1,000 crore; FY27 capex to be substantially lower. - Future capex focus on medium-ticket size projects utilizing existing infrastructure for faster turnaround and returns. - Emphasis shifting towards innovation-led growth and value-added chemistry as current capex cycle concludes.

- The company expects steady volume growth supported by capacity expansions and debottlenecking initiatives, particularly in MMA, with incremental capacity coming online from Q4 FY26 and through FY27. - Market expansion efforts continue globally, especially in Europe, Middle East, and Africa, alongside recovery in U.S. volumes as tariff issues are addressed. - Medium-scale, innovation-led capex projects over the next 2-3 years are aimed at quick turnaround and significant return generation. - The company anticipates gradual recovery in volumes in agrochemicals and other specialty chemicals segments as trade and margin pressures ease. - Volume sustainability at current levels is expected to drive operating leverage, supporting margin and revenue growth. - Long-term volume visibility remains healthy across most businesses despite near-term uncertainties. - Overall revenue growth is driven by proactive market diversification, increased global footprint, and ongoing capacity additions.

- The company expects medium-term volume visibility to remain healthy across most businesses despite near-term uncertainties (Page 3). - EBITDA aspirations for FY28 remain a firm commitment, supported by volume ramp-up, cost optimization, and monetization of ongoing capex projects (Page 3). - Incremental capacity additions such as the multipurpose plant, calcium chloride facility, and PEDA project will drive profitable growth and volume ramp-up in the next 12-18 months (Pages 5, 6). - Operating leverage is a key driver of margin improvement, expected to support EBITDA growth as volumes increase (Page 6). - Cost-cutting initiatives totaling INR150-200 crore are underway, with 40-50% of benefits yet to flow through, indicating further profit improvement potential (Page 13). - Management aims for disciplined capital expenditure focusing on medium-scale projects with fast turnaround and significant returns, avoiding large-ticket capex for the next 2-3 years (Pages 5, 7). - The balance sheet debt-to-EBITDA ratio may have peaked, with expectations of improvement going forward, supporting financial stability (Page 20).

- The transcript does not explicitly mention the current or expected order book or pending orders for Aarti Industries. - However, management indicated they have active conversations and decent relationships with customers for upcoming projects such as multipurpose plant and PEDA. - They clarified that none of the upcoming projects have take-or-pay contracts, implying orders are not fully secured with firm commitments. - Confidence in volume placement exists, supported by ongoing customer engagement. - The company is commissioning several projects sequentially, suggesting a healthy pipeline but without specific orderbook data disclosed. - Overall, long-term volume visibility remains healthy across most businesses despite near-term uncertainties.

- There is no specific mention of any new fundraising through debt or equity in the transcript. - The company emphasizes disciplined capital execution with no blockbuster capex planned in the next 2-3 years. - Future capex will be medium-scale projects focused on quick turnaround and significant returns using existing infrastructure. - The focus remains on managing the balance sheet prudently, with no indication of immediate or planned large-scale fundraising. - Debt-to-EBITDA may have already peaked, and the company expects improvement going forward. - Finance costs may increase modestly due to new projects, but interest rate softening is anticipated to help manage costs. - Overall, the company aims to maintain a stable debt profile and manage leverage amid ongoing capex and innovation-led growth.